Full-Time

Digital Marketing Specialist

Radiology

Posted on 11/1/2025

Akumin

Akumin

1,001-5,000 employees

Outsourced radiology and oncology services

No salary listed

Remote in USA + 1 more

More locations: Tampa, FL, USA

Remote

Category
Growth & Marketing (2)
,
Requirements
  • 2 years proven experience in digital marketing, preferably in healthcare, radiology, or oncology sectors
  • Experience developing and implementing successful digital marketing campaigns across multiple channels
  • Strong background in strategizing and executing marketing plans that align with business objectives and target audience needs
  • Proficiency with analytics tools like Google Analytics (G4); ability to analyze data and derive actionable insights
  • Understanding of digital marketing tools and platforms (e.g., customer relationship management software, search engine optimization/SEM tools, Content Management Systems)
  • Excellent written and verbal communication skills for effective messaging and stakeholder engagement
  • Demonstrated ability to manage multiple projects simultaneously with attention to detail and follow-through
  • Travel may be required up to 10%
Responsibilities
  • Develop and execute digital marketing strategies aligned with the business objectives of the Radiology and Oncology divisions, incorporating market analysis, competitive insights, and targeted audience segmentation. This includes planning and overseeing web, SEO/SEM, email, social media, and display advertising campaigns to ensure cohesive and effective promotion of services across business-to-business (B2B), business-to-physician (B2P), and direct-to-consumer (DTC) channels.
  • Oversee the creation and dissemination of engaging, high-quality content across all digital platforms, ensuring it effectively communicates the divisions' value propositions and enhances online visibility. Manage the content strategy, including SEO optimization and consistency across digital channels, while ensuring compliance with healthcare industry regulations.
  • Utilize analytics to evaluate the performance of digital marketing initiatives, leveraging data to drive decisions and optimize campaigns for better engagement, conversion, and ROI. This involves analyzing customer interactions, conversions, and NPS to refine marketing strategies, improve user experience, and achieve measurable business growth.
  • Serve as the primary liaison between operations, sales, product development, and other key stakeholders to align digital marketing efforts with overall business goals. Engage with healthcare professionals and external vendors/partners to gather insights that inform targeted marketing strategies, ensuring collaborative execution and alignment.
  • Explore and implement new digital technologies (including AI) and methodologies to enhance marketing efficiency and impact, staying abreast of industry trends and best practices. Manage the digital marketing budget judiciously, allocating resources strategically to initiatives that offer the highest value and adjusting plans based on performance analytics and evolving business needs. Participate in monthly meetings with joint venture partners to communicate progress and align on digital marketing strategies, ensuring consistent exchange of insights and best practices.
  • Perform other duties as assigned.
Desired Qualifications
  • 5 years preferred experience in digital marketing, preferably in healthcare, radiology, or oncology sectors
  • Skilled in managing budgets with a track record of maximizing ROI on marketing expenditures
  • Capability to adapt to new technologies and stay abreast of the changing digital landscape

Akumin provides outsourced radiology and oncology services to hospitals, health systems, and physician groups across the United States through a network of fixed-site outpatient imaging centers and outpatient radiology and oncology services. It operates imaging centers and partners with healthcare facilities to offer diagnostic imaging, interpretation, and related outpatient services at scale across 47 states. Its nationwide focus on outsourced radiology and oncology allows hospitals to access imaging and cancer-care resources without maintaining all services in-house. The company aims to be a trusted partner for healthcare providers by delivering reliable, scalable imaging and cancer-care services that improve patient access to diagnostics and treatment.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Plantation, Florida

Founded

1997

Simplify Jobs

Simplify's Take

What believers are saying

  • Stonepeak invests $154M for long-term growth capital.
  • Debt restructures to new notes due 2031 at 8.75-9.75%.
  • Private equity drives steady diagnostic imaging deals in 2025.

What critics are saying

  • RadNet acquisitions capture Akumin's MRI market share.
  • Stonepeak strips assets post-privatization in 18-36 months.
  • Alliance HealthCare poaches radiation oncology referrals.

What makes Akumin unique

  • Akumin AXIS Drop Trailer expands mobile imaging capabilities.
  • Relocatable MRI suites launched at RSNA meeting.
  • National network offers outpatient imaging and radiation therapy.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Akumin who can refer or advise you

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

-12%

1 year growth

-12%

2 year growth

-12%
Innovate Healthcare
Jan 5th, 2026
Akumin secures $154M investment and restructures debt to extend repayment timeline to 2031

Akumin Inc. has secured $154 million in new capital from Stonepeak, an alternative investment firm, to support long-term growth of its imaging and radiation oncology services. The company is also restructuring its debt with noteholders representing over 95% of its outstanding senior secured notes. Under the agreement, Akumin's existing debt will be exchanged for new senior secured notes due in 2031, carrying a 9.75% interest rate that can drop to 8.75% if certain credit targets are met. The company's revolving credit facility, with roughly $119 million outstanding, will convert into preferred equity or move to a lower-priority position. The restructuring follows Akumin's recent launch of new offerings at the Radiological Society of North America meeting, including its Axis Drop Trailer and relocatable MRI suites.

Cantech Letter
Oct 23rd, 2023
Akumin likely won’t get a better offer than Stonepeak, Clarus says

The deal from private equity firm Stonepeak to acquire Akumin likely won’t be topped, says Clarus Securities analyst Noel Atkinson.

PR Newswire
Oct 20th, 2023
Akumin Inc. Reaches Agreement With Stonepeak To Become A Private Company

Financial restructuring to fortify balance sheet and provide liquidity runway for next stage of growthApprovals received from key stakeholders across capital structure; transaction will be implemented through prepackaged court-supervised process; Expected to obtain court approval within the next 45 daysBusiness will continue to operate as usual without interruption; trade creditors, employees, and other partners expected to continue to be paid in ordinary coursePLANTATION, Fla., Oct. 20, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ: AKU) (TSX: AKU) announced today that it has reached an agreement with Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, and the Company's stakeholders on the terms of a financial restructuring that will substantially improve the Company's balance sheet and provide ample liquidity to position Akumin for future success. The contemplated transaction will result in Akumin no longer being publicly listed.To effect the transaction in a timely and efficient manner, the Company and certain of its subsidiaries will commence prepackaged chapter 11 cases in the Southern District of Texas. The Company expects to obtain court approval of the transaction within the next 45 days and complete the transaction after receiving certain regulatory approvals. Throughout the process, Akumin's operations are expected to continue as normal

INACTIVE